Heike Schlichthaar

486 total citations
6 papers, 160 citations indexed

About

Heike Schlichthaar is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Heike Schlichthaar has authored 6 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Heike Schlichthaar's work include Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pancreatic function and diabetes (2 papers). Heike Schlichthaar is often cited by papers focused on Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pancreatic function and diabetes (2 papers). Heike Schlichthaar collaborates with scholars based in United Kingdom, United States and Sweden. Heike Schlichthaar's co-authors include Marcella Petrone, Phil Ambery, Maximilian Posch, Boaz Hirshberg, Victoria E R Parker, Darren Robertson, Tao Wang, David C. Hornigold, Leona Plum‐Mörschel and Tim Heise and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Heike Schlichthaar

6 papers receiving 158 citations

Peers

Heike Schlichthaar

EDM

MB

SURGE

PHARM

PHYSI

Elio Ippolito Italy

David C. D. Hope United Kingdom

Udi Fainberg Denmark

ANETTE L. SØNDERGAARD Denmark

Isaac Sinay Argentina

Björn A. Menge Germany

Masanori Togo Japan

Michael Mitry Germany

Terry Ridge United States

Xiaolin Dong China

Elio Ippolito Italy

Heike Schlichthaar

100 ×0.7

EDM

42 ×0.6

MB

39 ×0.7

SURGE

31 ×0.6

PHARM

32 ×1.4

PHYSI

Citations per year, relative to Heike Schlichthaar Heike Schlichthaar (= 1×) peers Elio Ippolito

Countries citing papers authored by Heike Schlichthaar

Since Specialization

Citations

This map shows the geographic impact of Heike Schlichthaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Schlichthaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Schlichthaar more than expected).

Fields of papers citing papers by Heike Schlichthaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Schlichthaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Schlichthaar. The network helps show where Heike Schlichthaar may publish in the future.

Co-authorship network of co-authors of Heike Schlichthaar

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Schlichthaar. A scholar is included among the top collaborators of Heike Schlichthaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Schlichthaar. Heike Schlichthaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Parker, Victoria, Heike Schlichthaar, Fraser W. Gibb, et al.. (2022). Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease. Diabetes Obesity and Metabolism. 24(7). 1360–1369. 56 indexed citations

2.

Parker, Victoria, Heike Schlichthaar, Fraser W. Gibb, et al.. (2021). 674-P: Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist in Patients with T2DM and DKD. Diabetes. 70(Supplement_1). 2 indexed citations

3.

Parker, Victoria, Thuong Hoang, Heike Schlichthaar, et al.. (2020). Efficacy and Safety of Cotadutide, a Dual GLP-1 and Glucagon Receptor Agonist, for Patients with Type 2 Diabetes Mellitus and CKD. Journal of the American Society of Nephrology. 31(10S). 348–348. 1 indexed citations

4.

Parker, Victoria E R, Darren Robertson, Tao Wang, et al.. (2019). 1017-P: Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity. Diabetes. 68(Supplement_1). 1 indexed citations

5.

Parker, Victoria E R, Darren Robertson, Tao Wang, et al.. (2019). Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist. The Journal of Clinical Endocrinology & Metabolism. 105(3). 803–820. 95 indexed citations

6.

Schlichthaar, Heike, et al.. (2008). Interstitielle Pneumonie und Sepsis durch Pasteurella-multocida-Infektion. DMW - Deutsche Medizinische Wochenschrift. 120(46). 1582–1586. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact